Glycoproteomics and clinical applications

Proteomics - Clinical Applications

Volumn 4, Issue 2, 2010, Pages 124-132

  Tian, Yuan ^a   Zhang, Hui ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical application; Diagnosis; Disease; Glycoproteomics

Indexed keywords

ADIPONECTIN; ALPHA 1 ANTITRYPSIN; BORONIC ACID DERIVATIVE; GLYCOSYLPHOSPHATIDYLINOSITOL; NEUROPILIN 1; PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; PROTEIN KINASE FYN; TRANSFERRIN;

BINDING SITE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER DIAGNOSIS; CHROMATOGRAPHY; DISEASE SEVERITY; GEL PERMEATION CHROMATOGRAPHY; GLYCOPROTEOMICS; HUMAN; IMMUNOGENICITY; LECTIN BINDING; LECTIN CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEOMICS; REVIEW; SOLID PHASE EXTRACTION; TUMOR GROWTH; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS PATHOGENESIS;

AMINO ACID SEQUENCE; ANIMALS; BIOMEDICAL RESEARCH; GLYCOPROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEOMICS;

EID: 77951930076     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900161     Document Type: Review

References (81)

1. Ito, S., Hayama, K., Hirabayashi, J., Enrichment strategies for glycopeptides. Methods Mol. Biol. 2009, 534, 195-203.
2. Gu, J., Taniguchi, N., Regulation of integrin functions by Nglycans. Glycoconj. J. 2004, 21, 9-15.
3. Wong, C. H., Protein glycosylation: new challenges and opportunities. J. Org. Chem. 2005, 70, 4219-4225.
4. Isaji, T., Gu, J., Nishiuchi, R., Zhao, Y. et al., Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J. Biol. Chem. 2004, 279, 19747-19754.
5. Ono, M., Handa, K., Withers, D. A., Hakomori, S., Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. Biochem. Biophys. Res. Commun. 2000, 279, 744-750.
6. Bruckner, K., Perez, L., Clausen, H., Cohen, S., Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 2000, 406, 411-415.
7. Zheng, M., Fang, H., Hakomori, S., Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. J. Biol. Chem. 1994, 269, 12325-12331.
8. Axford, J. S., Cunnane, G., Fitzgerald, O., Bland, J. M. et al., Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis. J. Rheumatol. 2003, 30, 2540-2546.
9. Holland, M., Yagi, H., Takahashi, N., Kato, K. et al., Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim. Biophys. Acta 2006, 1760, 669-677.
10. Lowe, J. B., Marth, J. D., A genetic approach to Mammalian glycan function. Annu. Rev. Biochem. 2003, 72, 643-691.
11. Wang, Z., Hart, G. W., Glycomic Approaches to Study GlcNAcylation: Protein Identification, Site-mapping, and Site-specific O-GlcNAc Quantitation. Clin. Proteomics 2008, 4, 5-13.
12. Varki, A., Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3, 97-130.
13. Fares, F., The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists. Biochim. Biophys. Acta 2006, 1760, 560-567.
14. Xin, L., Li, M., Jianjun, L., Recent developments in the enrichment of glycopeptides for glycoproteomics. Anal. Lett. 2008, 41, 10.
15. Wuhrer, M., Catalina, M. I., Deelder, A. M., Hokke, C. H., Glycoproteomics based on tandem mass spectrometry of glycopeptides. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2007, 849, 115-128.
16. Cummings, R. D., Kornfeld, S., Fractionation of asparaginelinked oligosaccharides by serial lectin-Agarose affinity chromatography. A rapid, sensitive, and specific technique. J. Biol. Chem. 1982, 257, 11235-11240.
17. Hirabayashi, J., Lectin-based structural glycomics: glycoproteomics and glycan profiling. Glycoconj. J. 2004, 21, 35-40.
18. Sharon, N., Lis, H., Lectins as cell recognition molecules. Science 1989, 246, 227-234.
19. Wiener, M. C., van Hoek, A. N., A lectin screening method for membrane glycoproteins: application to the human CHIP28 water channel (AQP-1). Anal. Biochem. 1996, 241, 267-268.
20. Bundy, J. L., Fenselau, C., Lectin and carbohydrate affinity capture surfaces for mass spectrometric analysis of microorganisms. Anal. Chem. 2001, 73, 751-757.
21. Xiong, L., Andrews, D., Regnier, F., Comparative proteomics of glycoproteins based on lectin selection and isotope coding. J. Proteome Res. 2003, 2, 618-625.
22. Bunkenborg, J., Pilch, B. J., Podtelejnikov, A. V., Wisniewski, J. R., Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics 2004, 4, 454-465.
23. Ghosh, D., Krokhin, O., Antonovici, M., Ens, W. et al., Lectin affinity as an approach to the proteomic analysis of membrane glycoproteins. J. Proteome Res. 2004, 3, 841-850.
24. Mechref, Y., Zidek, L., Ma, W., Novotny, M. V., Glycosylated major urinary protein of the house mouse: characterization of its N-linked oligosaccharides. Glycobiology 2000, 10, 231-235.
25. Yamamoto, K., Tsuji, T., Osawa, T., Analysis of asparaginelinked oligosaccharides by sequential lectin-affinity chromatography. Methods Mol. Biol. 1998, 76, 35-51.
26. Kaji, H., Saito, H., Yamauchi, Y., Shinkawa, T. et al., Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat. Biotechnol. 2003, 21, 667-672.
27. Yang, Z., Hancock, W. S., Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J. Chromatogr. A 2004, 1053, 79-88.
28. Wang, Y., Wu, S. L., Hancock, W. S., Approaches to the study of N-linked glycoproteins in human plasma using lectin affinity chromatography and nano-HPLC coupled to electrospray linear ion trap--Fourier transform mass spectrometry. Glycobiology 2006, 16, 514-523.
29. Madera, M., Mechref, Y., Novotny, M. V., Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides. Anal. Chem. 2005, 77, 4081-4090.
30. Madera, M., Mechref, Y., Klouckova, I., Novotny, M. V., Semiautomated high-sensitivity profiling of human blood serum glycoproteins through lectin preconcentration and multidimensional chromatography/tandem mass spectrometry. J. Proteome Res. 2006, 5, 2348-2363.
31. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
32. Tian, Y., Zhou, Y., Elliott, S., Aebersold, R., Zhang, H., Solidphase extraction of N-linked glycopeptides. Nat. Protoc. 2007, 2, 334-339.
33. Tian, Y., Kelly-Spratt, K. S., Kemp, C. J., Zhang, H., Indentification of glycoproteins from mouse skin tumors and plasma. Clin. Proteom. 2008.
34. Chen, R., Jiang, X., Sun, D., Han, G. et al., Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 2009, 8, 651-661.
35. Pan, S., Wang, Y., Quinn, J. F., Peskind, E. R. et al., Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach. J. Proteome Res. 2006, 5, 2769-2779.
36. McDonald, C. A., Yang, J. Y., Marathe, V., Yen, T. Y., Macher, B. A., Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome. Mol. Cell Proteomics 2009, 8, 287-301.
37. Lee, A., Kolarich, D., Haynes, P. A., Jensen, P. H. et al., Rat liver membrane glycoproteome: enrichment by phase partitioning and glycoprotein capture. J. Proteome Res. 2009, 8, 770-781.
38. Sparbier, K., Koch, S., Kessler, I., Wenzel, T., Kostrzewa, M., Selective isolation of glycoproteins and glycopeptides for MALDI-TOF MS detection supported by magnetic particles. J. Biomol. Tech. 2005, 16, 407-413.
39. Sparbier, K., Wenzel, T., Kostrzewa, M., Exploring the binding profiles of ConA, boronic acid and WGA by MALDITOF/TOF MS and magnetic particles. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2006, 840, 29-36.
40. Xu, Y., Wu, Z., Zhang, L., Lu, H. et al., Highly specific enrichment of glycopeptides using boronic acid-functionalized mesoporous silica. Anal. Chem. 2009, 81, 503-508.
41. Hagglund, P., Bunkenborg, J., Elortza, F., Jensen, O. N., Roepstorff, P., A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J. Proteome Res. 2004, 3, 556-566.
42. Alvarez-Manilla, G., Atwood 3rd, J., Guo, Y., Warren, N. L. et al., Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites. J. Proteome Res. 2006, 5, 701-708.
43. Helenius, A., Aebi, M., Intracellular functions of N-linked glycans. Science 2001, 291, 2364-2369.
44. Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., Dwek, R. A., Glycosylation and the immune system. Science 2001, 291, 2370-2376.
45. Bertozzi, C. R., Kiessling, L. L., Chemical glycobiology. Science 2001, 291, 2357-2364.
46. Cloos, P. A., Christgau, S., Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 2004, 5, 139-158.
47. O'Donnell, N., Intracellular glycosylation and development. Biochim. Biophys. Acta 2002, 1573, 336-345.
48. Glinsky, G. V., Antigen presentation, aberrant glycosylation and tumor progression. Crit. Rev. Oncol. Hematol. 1994, 17, 27-51.
49. Hakomori, S., Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 1996, 56, 5309-5318.
50. Dennis, J. W., Granovsky, M., Warren, C. E., Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1999, 1473, 21-34.
51. Couldrey, C., Green, J. E., Metastases: the glycan connection. Breast Cancer Res. 2000, 2, 321-323.
52. Hakomori, S., Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anticancer vaccines. Adv. Exp. Med. Biol. 2001, 491, 369-402.
53. Petrescu, A. J., Milac, A. L., Petrescu, S. M., Dwek, R. A., Wormald, M. R., Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology 2004, 14, 103-114.
54. Hongsachart, P., Huang-Liu, R., Sinchaikul, S., Pan, F. M. et al., Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma. Electrophoresis 2009, 30, 1206-1220.
55. Soltermann, A., Ossola, R., Kilgus-Hawelski, S., von Eckardstein, A. et al., N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer 2008, 114, 124-133.
56. Qiu, Y., Patwa, T. H., Xu, L., Shedden, K. et al., Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J. Proteome Res. 2008, 7, 1693-1703.
57. Ueda, K., Fukase, Y., Katagiri, T., Ishikawa, N. et al., Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectincoupled ProteinChip arrays. Proteomics 2009, 9, 2182-2192.
58. Liu, T., Qian, W. J., Gritsenko, M. A., Xiao, W. et al., High dynamic range characterization of the trauma patient plasma proteome. Mol. Cell Proteomics 2006, 5, 1899-1913.
59. Block, T. M., Comunale, M. A., Lowman, M., Steel, L. F. et al., Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. USA 2005, 102, 779-784.
60. Comunale, M. A., Wang, M., Hafner, J., Krakover, J. et al., Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J. Proteome Res. 2009, 8, 595-602.
61. Ohtsubo, K., Marth, J. D., Glycosylation in cellular mechanisms of health and disease. Cell 2006, 126, 855-867.
62. Hulsmeier, A. J., Paesold-Burda, P., Hennet, T., N-glycosylation site occupancy in serum glycoproteins using multiple reaction monitoring liquid chromatography-mass spectrometry. Mol. Cell Proteomics 2007, 6, 2132-2138.
63. Lewandrowski, U., Moebius, J., Walter, U., Sickmann, A., Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol. Cell Proteomics 2006, 5, 226-233.
64. Li, Y., Luo, L., Rasool, N., Kang, C. Y., Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J. Virol. 1993, 67, 584-588.
65. Jeffs, S. A., McKeating, J., Lewis, S., Craft, H. et al., Antigenicity of truncated forms of the human immunodeficiency virus type 1 envelope glycoprotein. J. Gen. Virol. 1996, 77, 1403-1410.
66. Hebert, D. N., Zhang, J. X., Chen, W., Foellmer, B., Helenius, A., The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J. Cell Biol. 1997, 139, 613-623.
67. Land, A., Braakman, I., Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum. Biochimie 2001, 83, 783-790.
68. Saunders, C. J., McCaffrey, R. A., Zharkikh, I., Kraft, Z. et al., The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J. Virol. 2005, 79, 9069-9080.
69. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W. et al., Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393, 648-659.
70. Reitter, J. N., Means, R. E., Desrosiers, R. C., A role for carbohydrates in immune evasion in AIDS. Nat. Med. 1998, 4, 679-684.
71. Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C. et al., HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 2002, 420, 678-682.
72. Kwong, P. D., Human immunodeficiency virus: refolding the envelope. Nature 2005, 433, 815-816.
73. Wei, X., Decker, J. M., Wang, S., Hui, H. et al., Antibody neutralization and escape by HIV-1. Nature 2003, 422, 307-312.
74. Johnson, W. E., Sauvron, J. M., Desrosiers, R. C., Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication. J. Virol. 2001, 75, 11426-11436.
75. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J. et al., Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 1990, 265, 10373-10382.
76. Mizuochi, T., Matthews, T. J., Kato, M., Hamako, J. et al., Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J. Biol. Chem. 1990, 265, 8519-8524.
77. Geyer, H., Holschbach, C., Hunsmann, G., Schneider, J., Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J. Biol. Chem. 1988, 263, 11760-11767.
78. Mizuochi, T., Spellman, M. W., Larkin, M., Solomon, J. et al., Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem. J. 1988, 254, 599-603.
79. Zhu, X., Borchers, C., Bienstock, R. J., Tomer, K. B., Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 2000, 39, 11194-11204.
80. Cutalo, J. M., Deterding, L. J., Tomer, K. B., Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry. J. Am. Soc. Mass Spectrom. 2004, 15, 1545-1555.
81. Go, E. P., Irungu, J., Zhang, Y., Dalpathado, D. S. et al., Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J. Proteome Res. 2008, 7, 1660-1674.